Company / Net Income
Cyclerion Therapeutics, Inc. Net Income History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$3.5M
FY2025
5-year range
-$77.8M / -$3.5M
FY2021-FY2025
Trend
+33.0%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from -$44M to -$4M over the past 2 years.
Based on SEC 10-K filings.
-$4M in FY2025.
Improved from -$44M to -$4M over the past 2 years.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, net income increased 33.0% year-over-year.
- Lowest net income in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -19.82 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.5M | +33.0% |
| FY2024 | -$5.3M | +88.1% |
| FY2023 | -$44.1M | +0.0% |
| FY2022 | -$44.1M | +43.3% |
| FY2021 | -$77.8M | +36.8% |
| FY2020 | -$123.0M | -6.7% |
| FY2019 | -$115.3M | - |
As of FY2025 · SEC 10-K Annual Filings · Updated Jun 24, 2026